Psychiatric News (11/1) reports, “Women who begin taking oral or transdermal estrogen or estrogen/progestin for menopause between the ages of 45 and 50 appear to be at greater risk of developing depression,” investigators concluded in a study that “included 825,238 women in Denmark who turned 45 years between 1995 and the end of 2017.” The findings were published online Nov. 1 in JAMA Network Open.

Related Links:

— “Oral, Transdermal Hormone Therapy for Menopause Before Age 50 May Increase Risk of Depression, Psychiatric News , November 1, 2022

The New York Times (11/1, Alcorn) reports, “An estimated one in eight deaths of Americans ages 20 to 64 in the years 2015-19 was the result of injuries or illness caused by excessive alcohol use, according to a” study that “assessed the effects of alcohol on people of working age, who accounted for nearly two-thirds of the country’s annual average of 140,000 alcohol-related deaths.” The study showed that “among those ages 20 to 49, one in five deaths was attributable to drinking, and for those ages 20 to 34, it was one in four.” The findings were published online in JAMA Network Open.

MedPage Today (11/1, Hamza) reports alcohol-attributed deaths “were more common among men than women (15% vs 9.4%), the authors wrote.”

CNN (11/1, Holcombe) also reports.

Related Links:

— “Alcohol Deaths Claim Lives of Working-Age Americans “Ted Alcorn, The New York Times, November 1, 2022

mHealth Intelligence (10/31, Melchionna) reports “that although in-person care is the preferred channel of care, telehealth use remains highly used among young adults and those engaging in primary care and mental health services,” according to a survey by Stericycle Communication Solutions in collaboration with Ipsos. In comparison, the “survey of 1,004 adults” found that “patients do not prefer virtual visits for specialties such as dermatology, pediatrics, ENT, cardiology, urology, gynecology, orthopedics, and pulmonology.”

Related Links:

— “Patients Prefer Telehealth for Primary Care, Mental Health Needs ” Mark Melchionna, mHealth Intelligence, October 31, 2022

Psychiatric News (10/31) reports, “Naltrexone may significantly reduce binge drinking among sexual and gender minority men (men who have sex with men) with mild or moderate alcohol use disorder,” investigators concluded in a 12-week study that “involved 120 sexual and gender minority men (one transgender male and 119 cisgender males) who reported at least one binge-drinking episode (five or more drinks on a single occasion) per week in the past three months, but who did not meet DSM-IV criteria for alcohol dependence.” The findings were published online Oct. 26 in the American Journal of Psychiatry, a publication of the American Psychiatric Association.

Related Links:

— “Naltrexone May Reduce Binge Drinking in Sexual and Gender Minority Men, Psychiatric News, October 31, 2022

MedPage Today (10/31, DePeau-Wilson) reports, “Children and adolescents who experience migraines are more likely to have anxiety and depression compared with those who don’t have migraines,” researchers concluded in a 51-study systematic review and meta-analysis, the findings of which were published online Oct. 31 in JAMA Pediatrics.

Related Links:

— MedPage Today (requires login and subscription)